A newer cancer drug may also be a treatment option for a leading intellectual and developmental disability. Fragile X syndrome (FXS) is the most common form of inherited intellectual disability.
Treatment
New funding moves David Gamm’s retinitis pigmentosa treatment research into phase two
A grant from Fighting Blindness Canada will allow Dave Gamm to further test the efficacy of an induced pluripotent stem cell (iPSC) derived treatment that aims to replace damaged photoreceptor cells and restore some measure of vision.